Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib might be used to treat hair loss.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.